TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules July 30, 1999
TCL Archive NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP March 11, 1988
TCL Archive DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says December 4, 1992
